27.09.2013 Views

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Malignant Lymphoma, hallmarks and concepts. Table 5 ± Primary genetic events and their effects in malignant<br />

lymphoma.<br />

Abbreviations: IGH Immunoglobulin heavy chain gene; IGL Immunoglobulin light chain gene; NFKB2 Nuclear<br />

factor kappa B2; BCL2 B-cell lymphoma/leukemia gene 2; API2 Apoptosis inhibiting protein 2; MALT1<br />

Mucosa-associated lymphoid tissue gene 1; BCL10 B-cell lymphoma/leukemia gene 10; CDK6 Cyclin-dependent<br />

kinase 6; IGK Immunoglobulin kappa light chain gene; PAX5 (BSAP) B-cell specific activator protein;<br />

BCL6 B-cell lymphoma/leukemia gene 6; MYC c-MYC oncogene; TCRA T-cell receptor alpha chain gene;<br />

TCO1 T-cell lymphoma/leukemia gene 1; NPM Nucleophosmin gene; ALK Anaplastic lymphoma kinase;<br />

TFG TRK-fused gene; TPM Tropomyosin gene; ATIC Aminoimidazole carboxamide ribonucleotide; formyltransferase/IMP<br />

cyclohydrolase gene.<br />

NHL entity Chromosomal<br />

aberration<br />

B-CLL t(14;19)(q32;q13) IGH<br />

BCL3<br />

t(10;14)(q24;q32) IGH<br />

NFKB2<br />

Follicular lymphoma t(14;18)(q32;q21) IGH<br />

BCL2<br />

Mantle cell lymphoma t(11;14)(q13;q32) IGH<br />

Cyclin D1<br />

Marginal zone B-cell lymphoma<br />

of MALT-type<br />

Splenic marginal zone B-cell<br />

lymphoma<br />

t(11;18)(q21;q21) API2<br />

MALT1<br />

t(1;14)(p22;q32) IGH<br />

BCL10<br />

t(2;7)(p12;q32) CDK6<br />

IGK<br />

Lymphoplasmacytic lymphoma t(9;14)(p13;q32) IGH<br />

PAX5 (BSAP)<br />

Genes involved Function<br />

?<br />

Induction of proliferation<br />

Resistance to apoptosis<br />

Dysregulation of cell-cycle<br />

control<br />

Resistance to apoptosis<br />

Resistance to apoptosis<br />

Dysregulation of cell-cycle<br />

control<br />

Enhanced response to<br />

proliferation signals<br />

Diffuse large B-cell lymphoma t(3;14)(q27;q32) IGH Transcriptional induction<br />

of proliferation<br />

Burkitt Lymphoma t(8;14)(q24;q32)<br />

t(2;8)(p12;q24)<br />

t(8;22)(q24;q11)<br />

Prolymphocytic leukemia of Ttype<br />

Anaplastic large cell lymphoma<br />

(T/0)<br />

Hepatosplenic c/d T-cell lymphoma<br />

Inv(14)(q11q32)<br />

t(14;14)(q11;q32)<br />

t(X;14)(q28;q11)<br />

t(2;5)(p23:q35)<br />

t(1;2)(q25;p23)<br />

t(2;3)(p23;q21)<br />

Inv(2)(p23;q35)<br />

Malignant Lymphoma, hallmarks and concepts<br />

BCL6 Resistance to differentiation<br />

IGH, IGL<br />

MYC<br />

TCRA<br />

TCL1<br />

TCRA<br />

MTCP1<br />

NPM-ALK<br />

TPM3-ALK<br />

TFG-ALK<br />

ATIC-ALK<br />

i(7)(q10) ? ?<br />

Transcriptional induction<br />

of proliferation (G1)<br />

Enhancement of cellular<br />

proliferation and survival<br />

519<br />

Constitutional activation of<br />

ALK tyrosin kinase

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!